Bak Cancer Research Results
Bak, BAK or BAK1: Click to Expand ⟱
| Source: |
| Type: |
Bak (also known as BAK or BAK1) is a protein that plays a crucial role in regulating cell death.
In cancer, the Bak protein is often inactivated or downregulated, allowing cancer cells to evade apoptosis and continue to proliferate uncontrollably.
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
H1650 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
PD-L1↑, eff↓, ROS↑, ER Stress↑, Apoptosis↑, BAX↑, Bak↑, BAD↑, Bcl-2↓, XIAP↓, survivin↓, cl‑PARP↑, CHOP↑, p‑eIF2α↑, ICD↑, eff↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ICD↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
XIAP↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, BAD↑, 1, Bak↑, 1, BAX↑, 1, Bcl-2↓, 1, survivin↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, p‑eIF2α↑, 1, ER Stress↑, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 1,
Immune & Inflammatory Signaling ⓘ
PD-L1↑, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 1, eff↑, 1,
Clinical Biomarkers ⓘ
PD-L1↑, 1,
Total Targets: 17
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bak, BAK or BAK1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:632 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page